ClinicalTrials.gg
RecruitingNCT07383038Updated Jun 8, 2026

Effect of Mobilization With Movement in Patients With Rotator Cuff Lesions

An interventional study of Mulligan mobilization and Conventional Physiotherapy in Rotator Cuff Tears and Physical Disability, sponsored by Kirsehir Ahi Evran Universitesi. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-06-08.

Sponsored by Kirsehir Ahi Evran Universitesi · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Aug 2025, registered Jan 2026).
  • Started Aug 2025; still recruiting 1 year 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 85 studies in Rotator Cuff Injuries with a site in Turkey — 19 open to participants now, 23 under way, none of them phase 3. Rotator Cuff Injuries · Turkey.

Planned enrollment
8th of 63
75 · median 44
Started
2025
with 11 others
No phase
63 of 85
11 open now
Primary completion
2026-08
later than 11 of 22 live
Registered
73rd of 85
by date
Lead sponsor
3 of 85
Kirsehir Ahi Evran Universitesi

Among the 85 studies in Rotator Cuff Injuries with a site in Turkey, this one is the 8th largest by planned enrollment of the 63 interventional ones, is one of 12 that started in 2025, is one of 63 with no phase, reaches primary completion later than 11 of the 22 other live ones, and was the 73rd registered.

By phase

85 studies; the count open now beside each. This study's row is marked.

No phasethis study63 · 11 open
Observational22 · 8 open

By the year they started

First in 2016; this study’s year is marked. 12 started in 2025.

Size and results

Median enrollment 44 across the 63 interventional studies, 50 across the 22 observational. Of the 57 that completed or were terminated, 1 (2%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 85 studies in Rotator Cuff Injuries with a site in Turkey, or all of them as a file.
02

Study summary

This randomized controlled trial aims to investigate the effects of Mobilization with Movement (MWM) on pain and functional status in individuals with rotator cuff lesions. Rotator cuff pathology is a common cause of shoulder pain and functional limitation, and impairments in proprioception may further compromise shoulder motor control and recovery.

Eligible participants with rotator cuff lesions will be randomly allocated into three groups: (1) Mobilization with Movement (MWM), (2) conventional physiotherapy, and (3) control group. All participants will be evaluated before and after the intervention period. Outcome measures will include shoulder-related functional disability assessed by the QuickDASH questionnaire, pain intensity, and shoulder joint position sense evaluated using an active repositioning test with a laser pointer during shoulder flexion.

The study is designed to determine whether MWM provides additional benefits over conventional treatment or task oriented training intervention in improving pain, function, and proprioceptive accuracy. The findings are expected to contribute to evidence-based conservative rehabilitation strategies for patients with rotator cuff lesions.

Read the detailed description

Rotator cuff lesions are among the most common causes of shoulder pain and functional limitation, particularly in middle-aged and older adults. Due to the wide range of motion and complex biomechanics of the glenohumeral joint, integrity of the rotator cuff muscles is essential for dynamic stability, coordinated movement, and precise joint positioning. Pathological changes in the rotator cuff may lead not only to pain and reduced functional capacity but also to impairments in proprioception, which can negatively affect motor control and increase the risk of recurrent injury.

Conservative management is widely recommended as the first-line treatment for rotator cuff lesions and typically includes therapeutic exercises, physical agents, and manual therapy techniques. Mobilization with Movement (MWM), developed within the Mulligan concept, is a manual therapy approach that combines sustained accessory joint mobilization with active, pain-free physiological movement. MWM is proposed to improve joint mechanics, reduce pain, and enhance neuromuscular and proprioceptive input. While previous studies have demonstrated the effectiveness of MWM in reducing pain and improving function in various musculoskeletal conditions, evidence regarding its effects on shoulder proprioception, particularly joint position sense, in individuals with rotator cuff lesions remains limited.

This randomized controlled trial is designed to evaluate the effects of MWM on pain, functional outcomes, and joint position sense in patients with rotator cuff lesions. Eligible participants diagnosed with rotator cuff pathology will be randomly assigned to one of three groups: (1) Mobilization with Movement (MWM) group, (2) conventional physiotherapy group, or (3) task oriented training group. Randomization will be performed after baseline assessment to ensure allocation concealment.

All participants will undergo standardized assessments at baseline (pre-intervention) and after completion of the intervention period (post-intervention). Functional status of the upper extremity will be evaluated using the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire. Pain intensity will be assessed using validated self-report measures. Shoulder proprioception will be assessed through a joint position sense test using an active repositioning method during shoulder flexion with a laser pointer system, recording the deviation from a predefined target point in centimeters.

The MWM group will receive manual therapy interventions based on Mulligan principles, applied by a trained physiotherapist, in addition to standard care. The conventional physiotherapy group will receive commonly used rehabilitation interventions excluding MWM techniques. The control group will not receive therapeutic intervention during the study period. All procedures will be conducted in accordance with the Declaration of Helsinki, and written informed consent will be obtained from all participants prior to enrollment.

The primary objective of this study is to determine whether MWM leads to superior improvements in pain, functional ability, and joint position sense compared with conventional physiotherapy and no intervention. Secondary objectives include evaluating the magnitude of treatment effects and exploring the relationship between changes in proprioception and functional outcomes. The results of this trial are expected to provide clinically relevant evidence regarding the role of Mobilization with Movement in conservative rehabilitation protocols for individuals with rotator cuff lesions.

03

Conditions studied

  • Rotator Cuff Tears
  • Physical Disability

Browse trials for

Keywords

  • rotator cuff lesions
  • Mulligan mobilization
  • joint position sense
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 65 years
  • Clinical and/or imaging-confirmed diagnosis of rotator cuff lesion (e.g., tendinopathy or partial tear)
  • Presence of shoulder pain for at least 3 months
  • Pain and functional limitation during shoulder movements
  • Ability to actively perform shoulder movements required for assessment and intervention
  • No physiotherapy or manual therapy treatment for the affected shoulder within the last 3 months

Exclusion criteria

Exclusion Criteria:

  • History of shoulder surgery on the affected side
  • Full-thickness rotator cuff tear or shoulder instability
  • Shoulder fracture, dislocation, or acute trauma within the past 6 months
  • Neurological disorders affecting the upper extremity (e.g., cervical radiculopathy, peripheral neuropathy)
  • Systemic inflammatory or rheumatologic diseases
  • Severe shoulder osteoarthritis or adhesive capsulitis
  • Current participation in another clinical trial
  • Use of injection in the affected shoulder within the last 3 months
  • Pregnancy
  • Inability to comply with the study protocol or assessment procedures
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
75 participants (estimated)

Study arms

  • Active comparator
    Conventional Physiotherapy Group

    Participants in this arm will receive a conventional physiotherapy program commonly used in the conservative management of rotator cuff lesions. The program will include therapeutic exercises, stretching, and physical therapy modalities aimed at reducing pain and improving shoulder function. Mobilization with Movement or other Mulligan-based manual therapy techniques will not be applied in this group.

    Other: Conventional Physiotherapy

  • Experimental
    Mobilization with Movement (MWM) Group

    Participants allocated to this arm will receive Mobilization with Movement interventions based on the Mulligan concept. The technique will involve the application of sustained accessory glenohumeral joint mobilization combined with active, pain-free shoulder movements. Interventions will be administered by a trained physiotherapist according to a standardized protocol. This group may also receive basic conventional physiotherapy components excluding other manual mobilization techniques.

    Other: Mulligan mobilization

  • No intervention
    Task-Oriented Training (Virtual Reality) Group

    Participants allocated to this arm will receive a task-oriented training program delivered through virtual reality (VR)-based rehabilitation applications. The intervention will consist of goal-directed and functional upper extremity activities designed to simulate daily living tasks and promote active shoulder use. Training tasks will target reaching, grasping, object manipulation, and multidirectional arm movements requiring coordination, accuracy, and motor control.

Interventions

  • OtherMulligan mobilization

    Participants assigned to the Mobilization with Movement (MWM) group will receive manual therapy based on the Mulligan concept. The intervention will consist of the application of sustained, pain-free accessory mobilization to the glenohumeral joint combined with active physiological shoulder movements, primarily in shoulder flexion and abduction. The direction and grade of mobilization will be individually determined according to the patient's symptoms and movement restrictions, ensuring that all movements are performed within a pain-free range. MWM interventions will be administered by a trained physiotherapist following a standardized treatment protocol. Each treatment session will last approximately 20-30 minutes and will be applied multiple times per week throughout the intervention period. The primary goal of the intervention is to improve joint mechanics, reduce pain, and enhance proprioceptive input by facilitating normal, pain-free movement patterns.

  • OtherConventional Physiotherapy

    Participants allocated to the conventional physiotherapy group will receive a standard rehabilitation program commonly used for rotator cuff lesions. The intervention will include therapeutic exercises targeting shoulder range of motion, strengthening of the rotator cuff and scapular stabilizing muscles, and stretching exercises for periarticular soft tissues. Physical therapy modalities such as heat or ultrasound may be applied as needed for pain management. This intervention will be delivered by a physiotherapist according to established clinical guidelines. Mobilization with Movement or other Mulligan-based manual therapy techniques will not be included in this group.

06

What researchers measure

Primary outcomes

  1. Quick Disabilities of the Arm, Shoulder and Hand questionnaire.

    Upper Extremity Functional Disability, Higher scores better outcomes

    Time frame: Baseline (pre-intervention) and at the end of the 8-week intervention period.

Secondary outcomes

  1. Visual Analog Scale

    Pain Intensity-Lower score better outcomes

    Time frame: Baseline (pre-intervention) and at the end of the 8-week intervention period.

  2. Joint Position Sense Error (cm)

    Shoulder Joint Position Sense-Proprioception was assessed by measuring joint position sense (JPS) using a laser.Lower score better outcomes

    Time frame: Baseline (pre-intervention) and at the end of the 8-week intervention period.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Ozlu O, Sahin M. The effect of mulligan mobilization technique application in addition to conventional physiotherapy on pain and joint range of motion in people with neck pain. J Bodyw Mov Ther. 2024 Jul;39:225-230. doi: 10.1016/j.jbmt.2024.02.009. Epub 2024 Mar 5. PubMed 38876630 ↗

Individual participant data

Plan to share: No — Individual participant data collected in this study will not be made publicly available. Aggregate data and study results will be reported in scientific publications and presentations without including any identifiable participant information.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for Aug 2026, 12 months after the start.

Of 228 non-industry interventional studies with no phase under Rotator Cuff Injuries, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 12 months is below that.

Counting every sponsor, half of 252 studies reached it within 23 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 20, 2026
First posted
Feb 3, 2026
StartActual
Aug 25, 2025
Primary completionEst.
Aug 25, 2026
CompletionEst.
Aug 28, 2026
Last update
Jun 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07383038
Responsible party
Ömer Faruk ÖZÇELEP (Dr, Kirsehir Ahi Evran Universitesi) — Principal investigator
First posted
Feb 3, 2026
Start date
Aug 25, 2025
Primary completion
Aug 25, 2026 (estimated)
Completion
Aug 28, 2026 (estimated)
Last update
Jun 8, 2026

Study contacts

Ömer Faruk Özçelep, PhD
Contact
omer.ozcelep@ahievran.edu.tr
+90 531 946 3777

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion